Sophos Adds Auto Scaling to Its Unified Threat Management

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sophos Adds Auto Scaling to Its Unified Threat Management for AWS Solution

LAS VEGAS, NV--(Marketwired - Oct 7, 2015) -  Sophos, a global leader in network and endpoint security solutions, today announced enhancements to its leading Unified Threat Management (UTM) solution designed for organizations of all sizes using Amazon Web Services (AWS). Sophos UTM 9 features Auto Scaling technology to ensure a user's security layer scales to match application needs without affecting performance. Sophos UTM 9 is integrated into the network access and application levels to deliver the flexibility and cost control of a cloud-based solution, and eliminates bottlenecks on the AWS architecture that other security solutions not designed to accommodate horizontal scaling, can cause.

The Sophos UTM 9 offers a suite of user-friendly security tools such as a web application firewall, an inline IPS, VPN gateway functionality, granular firewall and web access controls, with extensive real time and historical reporting to help AWS users meet their security needs.

Already placed as a Leader in the the Sept. 2015 Magic Quadrant for Unified Threat Management (UTM) the release of Sophos UTM 9 further strengthens Sophos' security offerings with enhanced cloud security for businesses utilizing third-party infrastructure to pursue their business goals. AWS users who take advantage of UTM gain access to security that is simple to deploy, mapping it to Auto Scaling rules that free administrators from minute-to-minute configuration changes.

"The new UTM with Auto Scaling demonstrates our commitment to businesses that want to take advantage of the AWS cloud environment and enjoy flexibility at scale," said Bryan Barney, senior vice president, Network Security Group at Sophos. "The Sophos UTM helps customers take full advantage of their AWS deployment without having to worry about under or overcommitting security resources."

UTM complements the infrastructure-level security provided by AWS for end-to-end protection. Whereas a rigid security environment can form a bottleneck negating much of the performance advantage of the cloud, by combining Auto Scaling features with layered functionality UTM gives businesses a dynamic security layer that supports even the most demanding applications.

"The Sophos UTM is an integral part of REAN security solution for AWS customers wanting to enhance their cloud security posture, especially customers in regulated industries like government, healthcare and financial services where security and compliance are a premium," said Sri Vasireddy, president, REAN Cloud Solutions. "The addition of Auto Scaling support in Sophos UTM is very beneficial to how our customers utilize AWS in a fail-safe architecture."

Availability Sophos UTM 9 is available now via the AWS Marketplace, where customers can select between a number of subscription models, including bring your own license and hourly billing. Customers with current cluster licenses can apply licenses to the updated version.

For data sheets, demonstration videos and more information on UTM 9 with Auto Scaling, visit http://sophos.com/aws .

About Sophos More than 100 million users in 150 countries rely on Sophos' complete security solutions as the best protection against complex threats and data loss. Simple to deploy, manage and use, Sophos' award-winning encryption, endpoint security, Web, email, mobile and network security solutions are backed by SophosLabs -- a global network of threat intelligence centers.

Sophos is headquartered in Oxford, UK, and is publicly traded on the London Stock Exchange under the symbol "SOPH." More information is available at www.sophos.com .

Contact: Lucy Millington Email Contact Phone: 781-494-5887

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
icles